http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103420979-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
filingDate 2012-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103420979-B
titleOfInvention The process for purification of Esomeprazole sodium
abstract The present invention relates to a kind of process for purification of Esomeprazole sodium.The process for purification of a kind of Esomeprazole sodium of the present invention, for from prochiral compound-thioether, through Esomeprazole sodium crude product refining of asymmetric oxidation reaction synthesis.Described process for purification comprises the following steps: with the Esomeprazole sodium crude product synthesized by asymmetric oxidation reaction for raw material, by rudimentary organic ketone by after described Esomeprazole sodium dissolving crude product, then add acetonitrile, after precipitation to be crystallized, filter, obtain first subcrystalline highly finished product; By above-mentioned highly finished product with after rudimentary Organic Alcohol heating for dissolving, cooling, after precipitation to be crystallized, filters, obtains second subcrystalline highly finished product; The optical purity of the Esomeprazole sodium highly finished product obtained brings up to more than 99.8% by 92% of crude product, and content is up to more than 99.5%.
priorityDate 2012-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03089408-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7895
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9579578
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411746874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419569664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7909
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452554216
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531968
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1031
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID192113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23674541

Total number of triples: 34.